Eight Advisory supported Gimv in the sale of a majority stake in outpatient rehabilitation specialist rehaneo to Fremman Capital

rehaneo, a leading provider of outpatient rehabilitation, aftercare, prevention, and occupational health management founded in 2020, welcomes Fremman Capital to its shareholder base. Fremman takes over the majority shareholding previously held by the European investment company Gimv. Founder and CEO Bruno Crone and co-founder and COO Christoph Dühr remain significantly invested in the company and continue their management roles.

Gimv is a European investment company with over 40 years of experience in private equity and is listed on Euronext Brussels and a member of the Euronext BEL ESG Index. Gimv currently has a portfolio of more than EUR 1.5 billion, consisting of around 60 portfolio companies with a total turnover of EUR 4.0 billion and more than 20,000 employees.

The transaction is subject to approval by the German antitrust authorities and is expected to close in Q1 2025.

Eight Advisory team members supporting this transaction:

• Financial due diligence: Marc Niclas (Partner), Heloise Campos (Director), Marco Benkert (Manager), Hugo Bauer (Analyst), Maxime Rogier (Analyst)